Specialists for T-cell prolymphocytic leukemia

37 physicians and care centers identified from ClinicalTrials.gov trial PIs, PubMed publications, and the NPPES NPI registry.

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

David Maloney
Rare Disease / Clinical Research
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
PI×11
Heng Mei
Rare Disease / Clinical Research
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
PI×4 76
Tapan M Kadia
Rare Disease Specialist
M D Anderson Cancer Center
Houston, Texas
PI×9
Jae Park, MD
Rare Disease / Clinical Research
Memorial Sloan Kettering Cancer Center
PI×14
Thomas C. Shea, MD
Rare Disease / Clinical Research
UNC Lineberger Comprehensive Cancer Center
PI×5
Colleen Delaney, MD
Rare Disease / Clinical Research
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
OLD GREENWICH, CT
PI×3
Steven Horwitz, MD
Rare Disease / Clinical Research
Memorial Sloan Kettering Cancer Center
PI×4
Ryotaro Nakamura
Rare Disease Specialist
City of Hope Medical Center
Duarte, California
PI×6
Filippo Milano, M.D
Rare Disease / Clinical Research
Fred Hutch/University of Washington Cancer Consortium
SEATTLE, WA
PI×7 2
Elizabeth Fox, MD
Rare Disease / Clinical Research
National Cancer Institute (NCI)
PI×5
Nancy Wells, DNSc, RN
Rare Disease / Clinical Research
Vanderbilt-Ingram Cancer Center
PI×2
Nirali N Shah, M.D.
Rare Disease / Clinical Research
National Cancer Institute (NCI)
PI×9
Claudio G. Brunstein, MD, PhD, M.D., PhD
Rare Disease / Clinical Research
Masonic Cancer Center, University of Minnesota
MINNEAPOLIS, MN
PI×6
Colleen Annesley, MD, M.D
Rare Disease / Clinical Research
Seattle Children's Hospital
SEATTLE, WA
PI×6
John C Reneau, MD, MD
Rare Disease / Clinical Research
Ohio State University Comprehensive Cancer Center
LAS VEGAS, NV
PI×1
Chitra Hosing, M.D
Rare Disease / Clinical Research
M.D. Anderson Cancer Center
HOUSTON, TX
PI×5
Pierluigi Porcu, M.D
Rare Disease / Clinical Research
Ohio State University
PHILADELPHIA, PA
PI×2
James N Kochenderfer, M.D., MD
Rare Disease / Clinical Research
National Cancer Institute (NCI)
BETHESDA, MD
PI×7
Margaret L. MacMillan, MD
Rare Disease / Clinical Research
Masonic Cancer Center, University of Minnesota
PI×4
Fate Trial Disclosure
Rare Disease / Clinical Research
FateTrialDisclosure@fatetherapeutics.com
PI×10
Ann Woolfrey, M.D
Rare Disease / Clinical Research
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
SEATTLE, WA
PI×5
Tom R. Fitch, M.D.
Rare Disease / Clinical Research
Mayo Clinic
GLENDALE, AZ
PI×1
Tamila Kindwall-Keller, DO
Rare Disease / Clinical Research
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
PI×1 19
Paul Armistead, MD, M.D., PhD
Rare Disease / Clinical Research
UNC Lineberger Comprehensive Cancer Center
CHAPEL HILL, NC
PI×1
Chet Bohac, PharmD, MD, MSc
Rare Disease / Clinical Research
Executive Medical Director, Clinical Development, Xencor, Inc.
PI×1
Nicole Lamanna, MD
Memorial Sloan Kettering Cancer Center
NEW YORK, NY
QC-verified PI×3
Jakub Svoboda, MD
University of Pennsylvania
PHILADELPHIA, PA
QC-verified PI×4
Scott C. Stromatt, M.D
Aptevo Therapeutics
KAMUELA, HI
QC-verified PI×1
Howard Burris, M.D
SCRI Development Innovations, LLC
NASHVILLE, TN
QC-verified PI×1
Mark Frohlich
Xcyte Therapies
SEATTLE, WA
QC-verified PI×1
Kamel LARIBI, Dr
French Innovative Leukemia Organisation
QC-verified PI×1
Karen Kaucic
MedImmune LLC
QC-verified PI×1
Benjamin Tomlinson
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
CLEVELAND, OH
QC-verified PI×2
Li xiangqun
Kecellitics Biotech Company Ltd
QC-verified PI×2
Minocher M Battiwalla, MD
National Heart, Lung, and Blood Institute (NHLBI)
NASHVILLE, TN
QC-verified PI×2
Bruno Carneiro de Medeiros, MD
Stanford University
STANFORD, CA
QC-verified PI×2
Carlos Ramos
Baylor College of Medicine - Texas Children's Hospital
QC-verified PI×4

More about T-cell prolymphocytic leukemia